| 1 |
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2024, 74(3): 229-263.
|
| 2 |
Bureau Of Medical Administration National, S Republic Of China. 原发性肝癌诊疗指南(2024年版) [J]. 中国实用外科杂志, 2024, 44(4): 361-386.
|
| 3 |
Petrowsky H, Fritsch R, Guckenberger M, et al. Modern therapeutic approaches for the treatment of malignant liver tumours [J]. Nat Rev Gastroenterol Hepatol, 2020, 17(12): 755-772.
|
| 4 |
Terzi E, Giamperoli A, Iavarone M, et al. Prognosis of single early-stage hepatocellular carcinoma (HCC) with CEUS Inconclusive Imaging (LI-RADS LR-3 and LR-4) is no better than typical HCC (LR-5) [J]. Cancers (Basel), 2022, 14(2): 336.
|
| 5 |
Fraquelli M, Nadarevic T, Colli A, et al. Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease [J]. Cochrane Database Syst Rev, 2022, 9(9): CD13483.
|
| 6 |
Jiang H Y, Chen J, Xia CC, et al. Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis [J]. World J Gastroenterol, 2018, 24(22): 2348-2362.
|
| 7 |
Feng Y, Qin XC, Luo Y, et al. Efficacy of contrast-enhanced ultrasound washout rate in predicting hepatocellular carcinoma differentiation [J]. Ultrasound Med Biol, 2015, 41(6): 1553-1560.
|
| 8 |
Xu HX, Lu MD, Liu LN, et al. Discrimination between neoplastic and non-neoplastic lesions in cirrhotic liver using contrast-enhanced ultrasound [J]. Br J Radiol, 2012, 85(1018): 1376-1384.
|
| 9 |
Fraquelli M, Nadarevic T, Colli A, et al. Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease [J]. Cochrane Database Syst Rev, 2022, 9(9): CD13483.
|
| 10 |
编写专家委员会肝内胆管癌病理诊断专家共识版. 肝内胆管癌病理诊断专家共识(2022版) [J]. 中华病理学杂志, 2022, 51(9): 819-827.
|
| 11 |
Ainora ME, Cerrito L, Liguori A, et al. Multiparametric dynamic ultrasound approach for differential diagnosis of primary liver tumors [J]. Int J Mol Sci, 2023, 24(10): 8548.
|
| 12 |
Yuan MX, Li R, Zhang XH, et al. Factors affecting the enhancement patterns of intrahepatic cholangiocarcinoma (ICC) on Contrast-Enhanced Ultrasound (CEUS) and their pathological correlations in patients with a single lesion [J]. Ultraschall Med, 2016, 37(6): 609-618.
|
| 13 |
Gismondo VG, Lico M, Teti A, et al. Diagnosis of intrahepatic cholangiocarcinoma with CEUS [J]. J Ultrason, 2024, 24(96): 20240005.
|
| 14 |
Li R, Yuan MX, Ma KS, et al. Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis [J]. PLoS One, 2014, 9(5): e98612.
|
| 15 |
Beaufrere A, Calderaro J, Paradis V. Combined hepatocellular-cholangiocarcinoma: An update [J]. J Hepatol, 2021, 74(5): 1212-1224.
|
| 16 |
Li R, Yang D, Tang C L, et al. Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography [J]. BMC Cancer, 2016, 16: 158.
|
| 17 |
Yang J, Zhang Y, Bao WY, et al. Comparison contrast-enhanced CT with contrast-enhanced US in diagnosing combined hepatocellular-cholangiocarcinoma: a propensity score-matched study [J]. Insights Imaging, 2024, 15(1): 44.
|
| 18 |
Schima W, Heiken J. LI-RADS v2017 for liver nodules: how we read and report [J]. Cancer Imaging, 2018,18(1): 14.
|
| 19 |
Kono Y, Lyshchik A, Cosgrove D, et al. Contrast Enhanced Ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS(R)): the official version by the American College of Radiology (ACR) [J]. Ultraschall Med, 2017, 38(1): 85-86.
|
| 20 |
Bartolotta TV, Terranova MC, Gagliardo C, et al. CEUS LI-RADS: a pictorial review [J]. Insights Imaging, 2020, 11(1): 9.
|
| 21 |
Vidili G, Arru M, Solinas G, et al. Contrast-enhanced ultrasound liver imaging reporting and data system: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis [J]. World J Gastroenterol, 2022, 28(27): 3488-3502.
|
| 22 |
Schellhaas B, Bernatik T, Bohle W, et al. Contrast-enhanced ultrasound algorithms (CEUS-LIRADS/ESCULAP) for the noninvasive diagnosis of hepatocellular carcinoma-A prospective multicenter DEGUM study [J]. Ultraschall Med, 2021, 42(2): 178-186.
|
| 23 |
Giorgio A, Montesarchio L, Gatti P, et al. Contrast-enhanced utrasound: a simple and effective tool in defining a rapid diagnostic work-up for small nodules detected in cirrhotic patients during surveillance [J]. J Gastrointestin Liver Dis, 2016, 25(2): 205-211.
|
| 24 |
Shin J, Lee S, Kim YY, et al. Contrast-enhanced ultrasound liver imaging reporting and data system category M: a systematic review and meta-analysis [J]. Ultrasonography, 2022, 41(1): 74-82.
|
| 25 |
Li F, Li Q, Liu Y, et al. Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017 [J]. Eur Radiol, 2020, 30(1): 461-470.
|
| 26 |
Caraiani C, Boca B, Bura V, et al. CT/MRI LI-RADS v2018 vs. CEUS LI-RADS v2017-can things be put together? [J]. Biology (Basel), 2021, 10(5): 412.
|
| 27 |
Ding J, Qin Z, Zhou Y, et al. Impact of revision of the LR-M criteria on the diagnostic performance of contrast-enhanced ultrasound LI-RADS [J]. Ultrasound Med Biol, 2021, 47(12): 3403-3410.
|
| 28 |
Zeng D, Xu M, Liang JY, et al. Using new criteria to improve the differentiation between HCC and non-HCC malignancies: clinical practice and discussion in CEUS LI-RADS 2017 [J]. Radiol Med, 2022, 127(1): 1-10.
|
| 29 |
Li CQ, Huang H, Ruan SM, et al. An assessment of liver lesions using a combination of CEUS LI-RADS and AFP [J]. Abdom Radiol (NY), 2022, 47(4): 1311-1320.
|
| 30 |
Gong W, Wu J, Wei H, et al. Combining serum AFP and CEUS LI-RADS for better diagnostic performance in Chinese high-risk patients [J]. Radiol Med, 2023, 128(4): 393-401.
|
| 31 |
Qiu Y, He J, Chen X, et al. The diagnostic value of five serum tumor markers for patients with cholangiocarcinoma [J]. Clin Chim Acta, 2018, 480: 186-192.
|
| 32 |
Ye J, Xie X, Liu B, et al. Imaging features on contrast-enhanced ultrasound and clinical characteristics of hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: comparison with Hepatitis B virus-related hepatocellular carcinoma[J]. Ultrasound Med Biol, 2017, 43(11): 2530-2536.
|
| 33 |
Yang J, Zhang Y H, Li J W, et al. Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma [J]. World J Gastroenterol, 2020, 26(46): 7325-7337.
|
| 34 |
Lee H, Kim H, Han H, et al. Microbubbles used for contrast enhanced ultrasound and theragnosis: a review of principles to applications [J]. Biomed Eng Lett, 2017, 7(2): 59-69.
|
| 35 |
Ren J, Lu Q, Fei X, et al. Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue(R) and Sonazoid(R) [J]. Eur Radiol, 2024, 34(6): 3795-3812.
|
| 36 |
Yang Y, Liu C, Yan J, et al. Perfluorobutane contrast-enhanced ultrasonography for the diagnosis of HCC: a systematic review and meta-analysis [J]. Abdom Radiol (NY), 2021, 46(10): 4619-4628.
|
| 37 |
Wang S, Yao J, Li K, et al. Nomogram based on Sonazoid contrast-enhanced ultrasound to differentiate intrahepatic cholangiocarcinoma and poorly differentiated hepatocellular carcinoma: a prospective multicenter study [J]. Abdom Radiol (NY), 2023, 48(10): 3101-3113.
|
| 38 |
Sugimoto K, Kakegawa T, Takahashi H, et al. Usefulness of modified CEUS LI-RADS for the diagnosis of hepatocellular carcinoma using Sonazoid [J]. Diagnostics (Basel), 2020, 10(10): 828.
|
| 39 |
Liao W, Que Q, Wen R, et al. Comparison of the feasibility and diagnostic performance of ACR CEUS LI-RADS and a modified CEUS LI-RADS for HCC in examinations using Sonazoid [J]. J Ultrasound Med, 2023, 42(11): 2501-2511.
|
| 40 |
Liu Q, Liu T, Liu X, et al. The efficacy of modified contrast-enhanced ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) using Sonazoid in diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis [J]. Quant Imaging Med Surg, 2024, 14(4): 2927-2937.
|
| 41 |
Dong Y, Chen S, Moller K, et al. Applications of dynamic contrast-enhanced ultrasound in differential diagnosis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in non-cirrhotic liver[J]. Ultrasound Med Biol, 2023, 49(8): 1780-1788.
|
| 42 |
Qiu S, Ding J, Wang Y, et al. Dynamic contrast-enhanced ultrasonography combined with LR-M classification criteria for differentiating malignant liver nodules at high risk for hepatocellular carcinoma [J]. Ultrasound Med Biol, 2024, 50(7): 1028-1033.
|